IDDF2022-ABS-0112 Clinical Features in Primary Biliary Cholangitis: a Retrospective Analysis of 52 Cases

Jingping Zhou,Meiya Chen,Fei Zhou,Ermei Chen,Ligang Chen,Jianlin Ren,Rui Li
DOI: https://doi.org/10.1136/gutjnl-2022-iddf.97
2022-01-01
Abstract:Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease with unknown etiology. The main objective of this study is to improve the early diagnosis and understanding of PBC. Methods A retrospective analysis was conducted using patients diagnosed with PBC between January 2018 and December 2021. Demographic and clinical data were collected. Data were analyzed using SPSS 16 version. Results 52 patients were included. The patients are between 40–86 years old. The mean age was 62 years and 86.5% were females. The ratio of females to males was 6.42:1. Eleven patients had poor outcomes such as primary hepatic carcinoma, chronic liver failure, hemorrhagic shock and death. The top three most common concomitant diseases were gallbladder and bile duct disease (28.8%), thyroid disease (21.2%) and diabetes (11.5%). 10 cases (19.2%) were diagnosed with PBC-AIH overlap syndrome. 43 cases (82%) were anti-mitochondrial antibody (AMA) positive. 37 cases (71%) were anti-nuclear antibody ANA, 27 cases (52%) were positive for anti-SSA and SSB. 10 cases were positive for anti-centromere antibody CENPB (19%), 3 cases were anti-SMA positive (5%), 5 cases were anti-gp210/sp100 positive (9%). The Hb and PT levels between male and female PBC patients were statistically different. The levels of Hb, PLT, ALT and TBA were statistically different between non-cirrhotic and cirrhotic groups. Logistic regression analysis showed that the OR values of SSB and age for predicting poor prognosis in PBC were 15.76 and 1.11 respectively. Conclusions PBC is most common in middle-aged and elderly women. AMA and ANA are important indicators for the diagnosis of PBC. The baseline of Hb, PLT, ALT and TBA levels are associated with disease progression.SSB and age are risk factors for adverse prognosis. Improvement in the PBC early diagnosis is essential to disease outcome.
What problem does this paper attempt to address?